Life Scientist > Life Sciences

Companies debate cell line R&D needs

01 August, 2002 by Melissa Trudinger

Executives of three leading stem cell research companies - Stem Cell Sciences CEO Peter Mountford, ES Cell International (ESI) CEO Robert Klupacs and BresaGen medical director Chris Juttner - have debated the need for new human embryonic stem cell lines and the availability of commercially owned cell lines for basic research.


Diversity will be key to Centre of Excellence success: DeVore

31 July, 2002 by Melissa Trudinger

Multi-disciplinary research will be crucial to the success of the Centre for Stem Cell and Tissue Repair, its new chief operating officer told a Melbourne stem cell conference yesterday.


Controversies dissuade stem cell researchers, says NIH director

31 July, 2002 by Melissa Trudinger

The deputy director for extramural research at the US National Institutes of Health (NIH) warned delegates at a stem cell conference in Melbourne yesterday that the high level of attention being paid to the controversial research was making it difficult to attract scientists to work in the field.


NHMRC readies itself for new stem cell laws

31 July, 2002 by Melissa Trudinger

National Health and Medical Research Council CEO Prof Alan Pettigrew told a stem cell conference in Melbourne yesterday that the council was already preparing to implement a new embryonic stem cell research and cloning Bill.


Ethics conference hears of therapeutic cloning doubts

29 July, 2002 by Melissa Trudinger

Stem cell researcher Prof Alan Trounson would support a moratorium on therapeutic cloning, but says that research into embryonic stem cells is still necessary.


Stem Cells Centre of Excellence to set IP rules

19 July, 2002 by Tanya Hollis

A series of meetings will take place this month to set the intellectual property ground rules for the new Centre for Stem Cells and Tissue Repair.


Cellular processing

12 July, 2002 by Ben Worthen

The latest computer to come out of the University of Southern California isn't newsworthy for its small size or computational power. It's notable because it is made from DNA, the microscopic acids that reside in every cell and are responsible for all life.


Lawyers suggest patent system could be used as ethics tool

08 July, 2002 by Iain Scott

Ethical concerns over issues like the use of embryonic stem cells in research could be addressed in the patent system, a new paper has argued.


Singapore could allow therapeutic cloning for stem cell research

08 July, 2002 by Tanya Hollis

A Singapore government ethics committee has recommended in favour of therapeutic cloning in a move that could prove to be a research boon for private Australian company ES Cell International (ESI).


How Stem Cell Sciences tapped Japan's biobusiness bid

01 July, 2002 by Tanya Hollis

The foundations for Japan's first stem cell company were laid in 1994 when two scientists from different countries met at an institute tens of thousands of kilometres from their respective homes.


Alzheimer's researcher wins Mayne Florey Medal

27 June, 2002 by Melissa Trudinger

The Australian Institute of Political Science has presented Prof Colin Masters with the 2002 Mayne Florey Medal, recognising his world-leading research into the cause of Alzheimer's disease and other brain diseases of the elderly.


We won't use ES cells: med institute

25 June, 2002 by Tanya Hollis

A children's research institute with a strong focus on gene therapy and stem cell work has declared it does not support human embryonic stem cell research.


Capillary Electrophoresis: complex technology for complex science

24 June, 2002 by Melissa Trudinger

Capillary electrophoresis (CE) is a technique that allows researchers to separate analytes based on their differential mobilities in aqueous media when an electric field is applied.


Adult stem cell research adds fuel to local debate

21 June, 2002 by Tanya Hollis

New research suggesting adult stem cells could be as flexible as embryonic stem cells has re-ignited debate over whether controversial Australian laws to permit research on human embryos should go ahead.


SCS establishes Japan's first stem cell company

20 June, 2002 by Tanya Hollis

Melbourne's Stem Cell Sciences (SCS) has added another block to its global network with the establishment of Japan's first stem cell company.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd